Cargando…
Repurposing a clinically approved prescription Colquhounia root tablet to treat diabetic kidney disease via suppressing PI3K/AKT/NF-kB activation
BACKGROUND: Growing clinical evidences show the potentials of Colquhounia root tablet (CRT) in alleviating diabetic kidney disease (DKD). However, its pharmacological properties and underlying mechanisms remain unclear. METHODS: ‘Drug target-Disease gene’ interaction network was constructed and the...
Autores principales: | Ma, Zhaochen, Liu, Yudong, Li, Congchong, Zhang, Yanqiong, Lin, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725443/ https://www.ncbi.nlm.nih.gov/pubmed/34980163 http://dx.doi.org/10.1186/s13020-021-00563-7 |
Ejemplares similares
-
Computational repurposing and preclinical validation of colquhounia root tablets for membranous nephropathy
por: Mao, Xia, et al.
Publicado: (2023) -
IGF-1 Facilitates Cartilage Reconstruction by Regulating PI3K/AKT, MAPK, and NF-kB Signaling in Rabbit Osteoarthritis
por: Hossain, Mohammad Amjad, et al.
Publicado: (2021) -
A Discovery of Clinically Approved Formula FBRP for Repositioning to Treat HCC by Inhibiting PI3K/AKT/NF-κB Activation
por: Zhang, Yanqiong, et al.
Publicado: (2020) -
NF-kB and the CLL microenvironment
por: O’Donnell, Alice, et al.
Publicado: (2023) -
Soyasaponins Can Blunt Inflammation by Inhibiting the Reactive Oxygen Species-Mediated Activation of PI3K/Akt/NF-kB Pathway
por: Zha, Longying, et al.
Publicado: (2014)